These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21470019)

  • 21. Eplerenone in patients with systolic heart failure and mild symptoms.
    Zannad F; McMurray JJ; Krum H; van Veldhuisen DJ; Swedberg K; Shi H; Vincent J; Pocock SJ; Pitt B;
    N Engl J Med; 2011 Jan; 364(1):11-21. PubMed ID: 21073363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eplerenone: cardiovascular protection.
    Brown NJ
    Circulation; 2003 May; 107(19):2512-8. PubMed ID: 12756192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Eplerenone Post-AMI Heart Failure Efficacy and survival study (EPHESUS)].
    Takata Y; Asano K; Yamashina A
    Nihon Rinsho; 2005 Mar; 63 Suppl 3():336-41. PubMed ID: 15813091
    [No Abstract]   [Full Text] [Related]  

  • 24. Eplerenone--a novel selective aldosterone blocker.
    Zillich AJ; Carter BL
    Ann Pharmacother; 2002 Oct; 36(10):1567-76. PubMed ID: 12243608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eplerenone (GD Searle & Co).
    Martin J; Krum H
    Curr Opin Investig Drugs; 2001 Apr; 2(4):521-4. PubMed ID: 11566010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacology profile and clinical findings of Selara Tablets (eplerenone)].
    Nomura S; Tabira J; Hayashi T; Hamada Y
    Nihon Yakurigaku Zasshi; 2008 Oct; 132(4):227-35. PubMed ID: 18854625
    [No Abstract]   [Full Text] [Related]  

  • 27. [Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study].
    Watanabe J
    Nihon Rinsho; 2007 Apr; 65 Suppl 4():543-6. PubMed ID: 17508588
    [No Abstract]   [Full Text] [Related]  

  • 28. Selection of a mineralocorticoid receptor antagonist for patients with hypertension or heart failure.
    Iqbal J; Parviz Y; Pitt B; Newell-Price J; Al-Mohammad A; Zannad F
    Eur J Heart Fail; 2014 Feb; 16(2):143-50. PubMed ID: 24464876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of aldosterone and aldosterone-receptor antagonists in heart failure.
    Khan NU; Movahed A
    Rev Cardiovasc Med; 2004; 5(2):71-81. PubMed ID: 15184841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The use of aldosterone antagonists in the cardiovascular diseases].
    Trzaska E; GumuĊ‚ka W; Makulska-Nowak HE
    Kardiol Pol; 2009 Jun; 67(6):667-71. PubMed ID: 19618325
    [No Abstract]   [Full Text] [Related]  

  • 31. [REMINDER Study: myocardial infarct without heart failure: does eplerenone have an advantage?].
    Overbeck P
    MMW Fortschr Med; 2013 Mar; 155 Spec No 1(1):20. PubMed ID: 24260911
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of aldosterone blockade in managing heart failure: new and emerging treatment options. Introduction.
    Aforismo JF
    Am J Health Syst Pharm; 2004 May; 61 Suppl 2():S2-3. PubMed ID: 15160832
    [No Abstract]   [Full Text] [Related]  

  • 33. The month after a novel tale on eplerenone, but with a different ending.
    Emdin M; Pastormerlo LE; Passino C
    J Am Coll Cardiol; 2011 Nov; 58(19):1967-9. PubMed ID: 22032707
    [No Abstract]   [Full Text] [Related]  

  • 34. Eplerenone: another drug to add to the mix?
    Bart BA; Nelson S
    J Am Coll Cardiol; 2013 Oct; 62(17):1594-5. PubMed ID: 23810879
    [No Abstract]   [Full Text] [Related]  

  • 35. Spironolactone in heart failure--a revived role for an old drug.
    Bradley C
    Intensive Crit Care Nurs; 2000 Dec; 16(6):403-4. PubMed ID: 11091472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adherence to aldosterone-blocking agents in patients with heart failure.
    Margolis J; Gerber RA; Roberts C; Gheorghiade M
    Am J Ther; 2010; 17(5):446-54. PubMed ID: 20844344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of aldosterone receptor blockade in the management of cardiovascular disease.
    Liew D; Krum H
    Curr Opin Investig Drugs; 2002 Oct; 3(10):1468-73. PubMed ID: 12431020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eplerenone treatment of aortic stenosis. [letter].
    Marciniak TA
    Am Heart J; 2009 Mar; 157(3):e15; author reply e17. PubMed ID: 19249405
    [No Abstract]   [Full Text] [Related]  

  • 39. Mineralocorticoid receptor antagonists and endothelial function.
    Maron BA; Leopold JA
    Curr Opin Investig Drugs; 2008 Sep; 9(9):963-9. PubMed ID: 18729003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spironolactone in the management of congestive heart failure.
    Kayser SR
    Prog Cardiovasc Nurs; 2000; 15(4):145-8. PubMed ID: 11098527
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.